Phase II clinical trial of advanced stage ymphoblastic lymphoma. A Japanese Pediatric Cooperative Study
Phase 2
- Conditions
- Advanced stage lymphoblastic lymphoma of children.
- Registration Number
- JPRN-UMIN000002212
- Lead Sponsor
- Japanese Pediatric Leukemia/Lymphoma Study Group(JPLSG)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 124
Inclusion Criteria
Not provided
Exclusion Criteria
1, Down's syndrome 2, previous malignancy of any type 3, Prior stem cell or organ transplantation 4, Congenital or acquired immunodeficiency
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 3 year event-free survival
- Secondary Outcome Measures
Name Time Method (1) 3year overall survival (2)Incidence of therapy-rerated severe toxicity